Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, noviembre 18
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Colgate-Palmolive Co
CL
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$99.08
-0.53
-0.54%
Últ. Act.: Nov 18, 12:43 PM
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Colgate-Palmolive Financials
Colgate-Palmolive (CL) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Colgate-Palmolive Analysts Boost Their Forecasts After Upbeat Q3 Earnings
Colgate-Palmolive beats Q3 estimates, narrows 2026 sales outlook and raises EPS guidance; analysts lift price targets.
Avi Kapoor
Colgate-Palmolive Beats Q3 Estimates, Raises Profit Outlook Despite Weak US Demand, Rising Costs
Colgate-Palmolive beats Q3 2026 earnings and revenue estimates, raises profit and margin outlook, but faces weak US demand and rising costs.
Neeraj Jain
PRO
Colgate-Palmolive Narrows FY2026 Sales Guidance from $20.790B-$21.605B to $21.197B-$21.401B vs $21.406B Est
Colgate-Palmolive (NYSE:CL) narrows FY2026 sales outlook from $20.790 billion-$21.605 billion to $21.197 billion-$21.401 billion vs $21.406 billion estimate.
Benzinga Newsdesk
PRO
Colgate-Palmolive Q3 Adj. EPS $0.97 Beats $0.93 Estimate, Sales $5.369B Beat $5.334B Estimate
Benzinga Newsdesk
ExxonMobil, AbbVie On Deck Friday As Energy, Drug Growth Face Test
ExxonMobil headlines Friday’s reports, with investors watching whether strong energy production can sustain a sharp earnings recovery. AbbVie, Chevron, AstraZeneca, BP, Sanofi, General Dynamics, Regeneron
Benzinga Insights
Walmart’s Best Month Since 1999 Leads a Record Staples Rally: Is This a Warning Sign?
Walmart is on track for its best month since 1999 as XLP heads for a record October. Past staples surges like this often came before weaker markets.
Piero Cingari